STAGE II RENAL CELL CANCER AJCC V8
Clinical trials for STAGE II RENAL CELL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II RENAL CELL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II RENAL CELL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria could be key to stopping kidney Cancer's return
Disease control Not yet recruitingThis study is testing if adding a specific probiotic (CBM588) to a standard immunotherapy drug (pembrolizumab) can better prevent kidney cancer from coming back after surgery. The trial will involve 62 patients who have had surgery for high-risk kidney cancer. Researchers believe…
Matched conditions: STAGE II RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug aims to shrink tumors before kidney cancer surgery
Disease control Not yet recruitingThis study is testing if a new immunotherapy drug called ivonescimab can shrink tumors in patients with high-risk kidney cancer that hasn't spread. The drug is given by IV for about 3 months before the patient's standard surgery to remove the kidney. Researchers want to see if th…
Matched conditions: STAGE II RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC